|
Market Closed -
Warsaw S.E.
19:55:50 25/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 210.50 PLN | +1.84% |
|
-0.96% | +34.29% |
| 08-25 | Bayer Group Receives Approval For Sevabertinib In Japan For HER2-Mutant Non-Small Cell Lung Cancer | CI |
| 08-24 | CAC 40 pauses ahead of Nvidia and Jackson Hole |  |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- BAYN Stock
- BAY Stock
- Consensus Bayer AG
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
